The combination of a beat-and-raise quarter with a strategically bolt-on acquisition that expands recurring revenue and international exposure is a strong catalyst. Watch for NIRLAB's contribution to Q2 results and progress toward the $8M earn-out milestones tied to government contracts. The 180-day lock-up on seller shares limits near-term overhang.
Price Chart
Executive Summary
908 Devices completed the acquisition of NIRLAB AG for $15M upfront ($13M cash + $2M stock) plus up to $8M in earn-out shares, and reported Q1 2026 revenue of $13.4M (+14% YoY) with a net loss of $12.0M. The company raised its full-year 2026 revenue guidance to $67M-$70M (19%-25% growth), reflecting confidence in the combined business. The acquisition adds a recurring subscription-based narcotics detection platform, expanding the total addressable market.
Key Financial Metrics
Key Facts
- Acquired NIRLAB AG for $15M upfront ($13M cash + 293,368 shares) plus up to $8M in earn-out shares tied to 2027 revenue milestones
- Q1 2026 revenue $13.4M, +14% YoY; recurring revenue $4.0M (30% of total)
- Raised FY2026 revenue guidance to $67M-$70M (19%-25% growth), up from prior $64.5M-$67.5M
- Adjusted gross margin improved 290 bps to 57% in Q1 2026
- Cash position $111.7M with no debt; NIRLAB acquisition funded from balance sheet
- NIRLAB adds AI-powered NIR spectroscopy for narcotics detection with over 1M field analyses and a high-retention subscription model
Financial Impact
$15M upfront plus up to $8M earn-out; Q1 revenue $13.4M (+14% YoY); guidance raised to $67M-$70M
Risk Factors
- Integration risk with Swiss-based NIRLAB (15 employees, new geography)
- Earn-out milestones depend on securing government contracts by Dec 2027 — execution risk
- Net loss from continuing operations widened to $12.0M in Q1 2026 vs $9.8M in Q1 2025
- Stock-based compensation and contingent consideration volatility may distort GAAP earnings
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-055912 |
| Document: tm2613572d1_ex99-1.htm | 0001104659-26-055912 |
| Document: tm2613572d1_8k.htm | 0001104659-26-055912 |
| Document: tm2613572d1_ex99-2.htm | 0001104659-26-055912 |
| Document: 0001104659-26-055912-index-headers.html | 0001104659-26-055912 |
| Document: 0001104659-26-055912-index.html | 0001104659-26-055912 |
| Document: 0001104659-26-055912.txt | 0001104659-26-055912 |
| 8-K Data (Synthetic) | 0001104659-26-055912 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 20d ago | 144 | $11.78 $11.83 | ▲ +0.42% | ▲ +1.40% | $12.38 (+5.09%) |
Sep 25, 2026 4w ago | Insider Cluster | $11.66 $12.80 | ▼ −9.78% | ▼ −8.57% | $12.38 (−6.17%) |
Aug 27, 2026 8w ago | Insider Cluster | $10.73 $10.05 | ▼ −6.34% | ▼ −6.45% | $12.38 (+15.38%) |
Aug 17, 2026 10w ago | Insider Cluster | $10.08 $11.00 | ▼ −9.13% | ▼ −9.33% | $12.38 (−22.82%) |
Aug 12, 2026 10w ago | Insider Cluster | $10.11 $10.35 | ▼ −2.37% | ▼ −4.34% | $12.38 (−22.45%) |
Aug 11, 2026 11w ago | 8-K | $10.01 $10.08 | ▲ +0.70% | ▲ +1.10% | $12.38 (+23.68%) |
Aug 7, 2026 11w ago | Insider Cluster | $8.80 $10.19 | ▲ +15.80% | ▲ +15.84% | $12.38 (+40.68%) |
Jul 7, 2026 15w ago | Insider Cluster | $7.88 $8.05 | ▲ +2.16% | ▲ +0.90% | $12.38 (+57.11%) |
Jul 2, 2026 16w ago | Insider Cluster | $8.42 $7.95 | ▼ −5.58% | ▼ −5.30% | $12.38 (+47.03%) |
Jun 13, 2026 19w ago | Institutional Cluster | $8.62 $8.66 | ▲ +0.46% | ▲ +1.85% | $12.38 (+43.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers